Search
for
Sort by
Research 511–540 of 1000+
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Therapeutic Androgen Receptor Ligands
- Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
- Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men.
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide)
- Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura
- Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions
- Finasteride Induced Gynecomastia
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men
- Exploring the Inhibitory Potential of Phytosterols β-Sitosterol, Stigmasterol, and Campesterol on 5-Alpha Reductase Activity in the Human Prostate: An In Vitro and In Silico Approach
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Facial Hidradenitis Suppurativa in a 28-Year-Old Male Responding to Finasteride
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- A comment on the post-finasteride syndrome
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer
- Effect of 1-mg Dose of Finasteride on Spermatogenesis and Pregnancy
- Economic Issues in the Treatment of BPH
- The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
- Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride
- Effect of finasteride on serum concentrations of dihydrotestosterone and testosterone in three clinically normal sexually intact adult male dogs.